Sign in Pull a receipt

ORMP

ORAMED PHARMACEUTICALS INC.

Healthcare · Biotechnology

$144.94 sample

+1.25 (+0.87%) 1D

Market cap

$479.9B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-26

Alerts

8

Price$144.94 +6.69% 3M daily closessample

146.05131.84

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26SEC10-Q filed
Oct 19INSInsider sell: Director
Oct 12INSInsider buy: 10% owner
Oct 05INSInsider sell: Chief Executive Officer
Sep 28INSInsider buy: Chief Executive Officer
Sep 17INSInsider sell: Chief Executive Officer
Sep 09INSInsider sell: Chief Financial Officer
Aug 31INSInsider sell: EVP, Operations

Sign up to see the real ORMP record →

Company facts

SEC EDGAR registration

Name: ORAMED PHARMACEUTICALS INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -18sample, -100 to +100
Reporting currency: USD

Who is positioning in ORMP

sample

Insiders: 24 insider transactions over 90 days, net selling, $374.6M
Congress: 4 members traded over 90 days
Institutions · 13F: 20 funds hold $5.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$30.8B +20.9% y/y

Q4 2024Q3 2026

Inventory$17.6B +9.4% y/y

Q4 2024Q3 2026

Accounts receivable$13.9B +12.1% y/y

Q4 2024Q3 2026

Total debt$36.0B +14.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $404.6B +7.1% 3M
Sample peer B: $411.3B -11.9% 3M
Sample peer C: $336.9B -8.6% 3M
Sample peer D: $468.1B +0.2% 3M
Sample peer E: $269.5B +10.9% 3M